Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 11.0

Eligibility Criteria:
Inclusion Criteria:~* Willing to be on acceptable method of birth control~* Have a Pap smear result of LSIL or ASCUS~* Is high risk HPV positive~Exclusion Criteria:~* No evidence of high-grade disease or glandular abnormalities,~* Complete visualization of all lesion margins and the transformation zone,~* No uncontrolled significant medical illness or sexually transmitted infections,~* Taking any restricted medications such as interferon, immunomodulators, cytotoxic drugs, investigational drugs, steroids.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: EXPERIMENTAL): None
- 4 (Type: EXPERIMENTAL): None
- 5 (Type: EXPERIMENTAL): None
- 6 (Type: EXPERIMENTAL): None
- 7 (Type: EXPERIMENTAL): None
- 8 (Type: EXPERIMENTAL): None
- 9 (Type: EXPERIMENTAL): None
- 10 (Type: EXPERIMENTAL): None
- 11 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).